InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Anna Helena Constance Ljung. Director active across 1 company, notably Moberg Pharma AB (publ). Cumulatively, 1 reports have been recorded. History available since 7 July 2026. The latest transaction was filed on 7 July 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
1 of 1 declaration